The Talmud, the Hippocratic Corpus and Mark’s healing Jesus on infectious diseases

Through interacting with the sick, did Jesus contract infectious diseases or did he take preventive herbs to avoid them? During biblical times, infectious diseases were fatal. Diarrhoea, cough, pneumonia and skin diseases would quickly spread across villages or cities. Underscoring the seriousness w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hervormde teologiese studies Jg. 74; H. 1; S. 1 - 4
1. Verfasser: Dube, Zorodzai
Format: Journal Article
Sprache:Englisch
Veröffentlicht: AOSIS 30.07.2018
African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reformed Theological College of the Netherdutch Reformed Church of Africa at the Faculty of Theology of the University of Pretoria and Society for Practical Theology in South Africa
Schlagworte:
ISSN:0259-9422, 2072-8050, 2072-8050
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Through interacting with the sick, did Jesus contract infectious diseases or did he take preventive herbs to avoid them? During biblical times, infectious diseases were fatal. Diarrhoea, cough, pneumonia and skin diseases would quickly spread across villages or cities. Underscoring the seriousness with which prevention of infectious diseases was taken, 213 of the 613 biblical commandments concern hygiene. This study has two tasks: firstly, exploring the various techniques undertaken to avoid infectious diseases by looking at daily preventive hygienic activities. Secondly, given that Jesus was always in the company of sick crowds, the study re-describes Mark 1:4–45, where Jesus, after healing the leper, was forbidden from entering the city as indicative of fear against infectious diseases. Furthermore, the story (Mk 3:7–12) whereby Jesus requested a boat to create a gap between himself and the people is plausible from the perspective of infectious diseases.
ISSN:0259-9422
2072-8050
2072-8050
DOI:10.4102/hts.v74i1.4985